Back

Mechanisms of cardiac protection by pirfenidone in the post-myocardial infarction setting

27 August 2021 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters Pathophysiology and Mechanisms ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Oriol Iborra Egea

Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona (Spain)

178 More presentations in this session

Presentation thumbnail
The quest for GRACE 3.0: improving our beloved risk score with machine learning
Doctor J. Sousa (Porto, PT)
Abstract Slides
Presentation thumbnail
Percutaneous coronary interventions in patients with left main coronary artery pseudobifurcation lesions: 5-years follow-up
Associate Professor D. Maximkin (Moscow, RU)
Abstract Slides
Presentation thumbnail
Use of intima media thickness in the assessment of the development of preclinical atherosclerosis
Associate Professor R. Najafov (Baku, AZ)
Abstract Slides
Presentation thumbnail
Long term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention
Doctor O. Kobo (Hadera, IL)
Abstract Slides
Presentation thumbnail
Feasibility, safety and long term outcomes of complex left main bifurcation treatment using the nano inverted t stenting: a multicentre registry
Associate Professor G. Rigatelli (Rovigo, IT)
Abstract Slides

Access the full session

Session thumbnail
Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Effects of pirfenidone on scar size and ventricular remodeling after myocardial infarction: a preclinical study
21 May 2023
thumbnail
Congress Presentation
Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy
28 August 2022
thumbnail
Congress Presentation
Circulating pro fibrotic protein promotes fibrosis in liver and heart
1 September 2019
thumbnail
Congress Presentation
Specialized pro-resolving mediators prevents cardiac dysfunction by modulating Ca2+ handling and NRF2 axis
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources